Twist Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Twist Bioscience Corporation on January 8, 2020, reporting events occurring on January 3, 2020. The company is incorporated in Delaware and trades on The Nasdaq Global Select Market under the symbol TWST. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
On January 3, 2020, Frederick Craves, Ph.D., notified the Company of his decision not to stand for re-election to the Board of Directors at the Annual Meeting scheduled for February 4, 2020. His resignation as a Class II director will become effective at the conclusion of his current term at that meeting.
Management Commentary and Risks
Dr. Craves explicitly stated that his decision not to seek re-election and his resignation were not the result of any disagreement with the Company regarding its operations, policies, or practices. No other risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Frederick Craves, Ph.D., is resigning from the Board of Directors effective at the February 4, 2020 Annual Meeting.
- The resignation is voluntary and not related to any disagreement with company management or strategy.
- The filing does not include financial results or guidance; investors should refer to the most recent 10-K or 10-Q for financial data.